About Bulkamid
Bulkamid is a company based in London (United Kingdom) founded in 2003 was acquired by Axonics in February 2021.. Bulkamid offers products and services including Bulkamid Hydrogel. Bulkamid operates in a competitive market with competitors including Axonics, Laborie Medical, Amber Therapeutics, NeuSpera Medical and UroMems, among others.
- Headquarter London, United Kingdom
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Axonics, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bulkamid
Bulkamid offers a comprehensive portfolio of products and services, including Bulkamid Hydrogel. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Injectable hydrogel for managing stress urinary incontinence symptoms.
Funding Insights of Bulkamid
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Bulkamid
Bulkamid has secured backing from 1 investor. Prominent investors backing the company include Axonics. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sacral neuromodulation devices are developed for urinary and bowel control.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Bulkamid
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Bulkamid
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bulkamid Comparisons
Competitors of Bulkamid
Bulkamid operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Axonics, Laborie Medical, Amber Therapeutics, NeuSpera Medical and UroMems, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Sacral neuromodulation devices are developed for urinary and bowel control.
|
|
| domain | founded_year | HQ Location |
Medical products for female lower urinary tract dysfunctions are provided.
|
|
| domain | founded_year | HQ Location |
Bioelectrical therapies for peripheral nervous system disorders are developed.
|
|
| domain | founded_year | HQ Location |
Miniaturized injectable neuromodulation devices are developed for chronic diseases.
|
|
| domain | founded_year | HQ Location |
Developer of active implantable devices for urological incontinence
|
|
| domain | founded_year | HQ Location |
Non-invasive wearable devices for pelvic floor strengthening are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Bulkamid
When was Bulkamid founded?
Bulkamid was founded in 2003.
Where is Bulkamid located?
Bulkamid is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
What does Bulkamid do?
Bulkamid was founded in 2003 and is based in London, United Kingdom. Operations focus on the medical sector, specifically urological treatments. A bulking agent is supplied for addressing stress urinary incontinence and bladder leaks in women. In-home treatment options are available, along with developed medications targeted at urinary issues during activities such as coughing, walking, or exercising. Services are directed toward normalizing these conditions factually.
Who are the top competitors of Bulkamid?
Bulkamid's top competitors include Axonics, NeuSpera Medical and Laborie Medical.
What products or services does Bulkamid offer?
Bulkamid offers Bulkamid Hydrogel.
Who are Bulkamid's investors?
Bulkamid has 1 investor. Key investors include Axonics.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.